Garg Mahek, Venugopalan Veena, Vouri Scott M, Diaby Vakaramoko, Iovine Nicole M, Wilson Debbie L, Park Haesuk
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Pharmacotherapy. 2024 Sep;44(9):701-710. doi: 10.1002/phar.4604. Epub 2024 Sep 6.
One of the goals established by the United States National Action Plan to Combat Antibiotic-Resistant Bacteria is to reduce inappropriate outpatient antibiotic prescriptions by 50% by 2020. Recent data on the achievement of this goal is lacking. The objective of our study was to examine recent trends in the appropriateness of oral antibiotic prescriptions dispensed to a commercially insured population in outpatient settings in the United States to quantify the relative trend in inappropriate antibiotic prescribing from 2010 to 2018.
Our cross-sectional analysis examined oral antibiotic prescriptions dispensed in outpatient settings using the IBM MarketScan Commercial Data from January 2010 to December 2018. Trends in the annual proportion of antibiotic prescriptions classified as appropriate, potentially appropriate, inappropriate, or without any medical visit during a 7 days look-back period were estimated using multivariable generalized linear models with Poisson distribution adjusting for beneficiaries' demographic and infectious conditions.
Approximately 170 million oral antibiotic prescriptions were dispensed to 86 million beneficiaries during 2010 to 2018. The mean age of the study population was 34.5 (±19.1) years, with 58.4% females and 24.6% children. We observed a 12.9% (95% Confidence Interval [CI] = 12.6%-13.2%; p < 0.01) decline in rates of antibiotic use, from 832 to 727 prescriptions per 1000 beneficiaries, from 2010 to 2018. The proportion of prescriptions classified as appropriate increased by 36.7% (95% CI = 36.4%-36.9%; p < 0.01); potentially appropriate prescriptions increased by 9.3% (95% CI = 9.1%-9.4%; p < 0.01); whereas inappropriate prescriptions and those without a medical visit declined by 11.3% (95% CI = 11.2%-11.4%; p < 0.01) and 14.0% (95% CI = 13.9%-14.2%; p < 0.01), respectively. Similar declining trends were observed in use and proportion of inappropriate prescriptions for broad-spectrum antibiotics. In 2018, amoxicillin and azithromycin were the most common appropriate and inappropriate prescription fills, respectively.
Although antibiotic use and inappropriate prescribing declined steadily from 2010 to 2018 in the United States, this study demonstrates that we have not achieved the national goal of reducing inappropriate antibiotic prescribing by 50%.
美国抗击抗生素耐药细菌国家行动计划确立的目标之一是,到2020年将门诊抗生素不适当处方减少50%。目前缺乏关于这一目标达成情况的最新数据。我们研究的目的是调查美国门诊环境中商业保险人群口服抗生素处方适宜性的近期趋势,以量化2010年至2018年不适当抗生素处方的相对趋势。
我们的横断面分析使用了IBM MarketScan商业数据,研究2010年1月至2018年12月门诊开出的口服抗生素处方。使用多变量广义线性模型和泊松分布,对受益人的人口统计学和感染状况进行调整,估计在7天回顾期内被分类为适当、潜在适当、不适当或无就诊记录的抗生素处方的年度比例趋势。
2010年至2018年期间,约向8600万受益人开出了1.7亿份口服抗生素处方。研究人群的平均年龄为34.5(±19.1)岁,女性占58.4%,儿童占24.6%。我们观察到抗生素使用率下降了12.9%(95%置信区间[CI]=12.6%-13.2%;p<0.01),从2010年的每1000名受益人832张处方降至2018年的727张。被分类为适当的处方比例增加了36.7%(95%CI=36.4%-36.9%;p<0.01);潜在适当处方增加了9.3%(95%CI=9.1%-9.4%;p<0.01);而不适当处方和无就诊记录的处方分别下降了11.3%(95%CI=11.2%-11.4%;p<0.01)和14.0%(95%CI=13.9%-14.2%;p<0.01)。在广谱抗生素的使用和不适当处方比例方面也观察到类似的下降趋势。2018年,阿莫西林和阿奇霉素分别是最常见的适当和不适当处方药物。
尽管2010年至2018年美国抗生素使用和不适当处方稳步下降,但本研究表明我们尚未实现将不适当抗生素处方减少50%的国家目标。